Also known as: PPB
Pharmacy and Poisons Board — Kenyan medicines regulator overseeing product safety, compliance inspections, and licensing of pharmaceutical professionals and premises.
Verbatim sentences from the source article.
Citizen Digital
… Oduor, and representatives from the Pharmacy and Poisons Board (PPB) and KEMRI.
Japan commits Ksh.3B to support Kenya's local vaccine manufacturingCapital News
… Between 2021 and 2025, the Pharmacy and Poisons Board (PPB) recorded 1,413 product quality complaints, coordinated 99 product recalls, received 32,833 adverse drug reaction reports and issued 18 public alerts on suspected falsified medicines. …
Duale Warns Fake Drugs Fuelling Treatment Failure and Preventable DeathsCitizen Digital
Viagra, HIV kits, Truvada among fake health products in Kenyan market; PPB warns By Tabitha Rotich July 01, 2026 03:04 (EAT) Add as a Preferred Source on Google Follow us Follow on Whatsapp Follow on Google Follow on Twitter Audio By Vocalize The Pharmacy and Poisons Board (PPB) …
Viagra, HIV kits, Truvada among fake health products in Kenyan market; PPB warnsThe Standard
… The AI Bill 2026 received its first reading in the Senate on April 2, 2026, while the lesser-known document, already in force, was issued by the Pharmacy and Poisons Board in February as guidelines for regulating medical device software in Kenya (MDSW). …
What AI Bill and PPB Software Device Rules Mean for Healthcare businessesThe Standard
… The Pharmacy and Poisons Board (PPB) says the fake products have been detected through enhanced market surveillance.Speaking during the launch of the Kenya National Action Plan on Substandard and Falsified Medical Products, PPB Director of Product Safety Dr Edward Abwao has warne …
Viagra, HIV test kits among counterfeit medical products flooding Kenyan marketThe Standard
… This is a milestone expected to strengthen oversight of medical products, boost local manufacturing, and improve access to safe and effective medicines.The Ministry of Health, through the Pharmacy and Poisons Board (PPB), is leading reforms aimed at elevating the country's regula …
Kenya in a drive to attain WHO medicine production level in the next five monthsCapital News
NAIROBI, Kenya, Jun 22 — The Pharmacy and Poisons Board (PPB) has arrested ninety-five individuals and closed forty-eight unlicensed medicine outlets during a week-long enforcement operation in Nairobi and Kajiado counties. …
Pharmacy Board shuts down 48 illegal medicine outlets, arrests 95 in major crackdownThe Standard
Audio By VocalizeThe Pharmacy and Poisons Board (PPB) has arrested 95 people and shut down 48 unlicensed pharmaceutical premises following a week-long crackdown in Nairobi's informal settlements and parts of Kajiado County. …
95 arrested as pharmacy board raids fake chemists in Nairobi slumsCapital News
… Key priorities included Kenya’s push to scale up local pharmaceutical manufacturing, strengthen regulation through the Pharmacy and Poisons Board, and deepen its role in global health diplomacy to ensure African interests are better represented in international decision-making. …
Duale, WHO Officials Hold Talks on Global Health Cooperation, Regional Health SecurityThe Pharmacy and Poisons Board is strengthening Kenya's medicines regulatory systems to ensure medical products are safe, effective and of assured quality, with enhanced oversight across the life cycle of medical products including inspections of manufacturers and wholesalers.
30 September 2026 · The Standard →
The Pharmacy and Poisons Board is strengthening Kenya's medicines regulatory systems to ensure medical products are safe, effective and of assured quality, with enhanced oversight across the life cycle of medical products including inspections of manufacturers and wholesalers.
30 September 2026 · The Standard →
Mission for Essential Drugs and Supplies (MEDS) has launched MEDS Devane Company Limited (MDCL), a commercial enterprise to supply private hospitals, clinics, pharmacies and other healthcare institutions with medicines, medical consumables, diagnostics and equipment, beginning operations on November 1 with an initial focus on Kenya before expanding to East Africa.
30 September 2026 · The Standard →
Kenya aims to manufacture at least half of its essential health products locally by 2030 to reduce import dependence and establish itself as a regional pharmaceutical manufacturing hub. Health Cabinet Secretary Aden Duale said the strategy, part of the 2026–2030 Health Products and Technologies Local Manufacturing Strategy, will strengthen domestic production while improving access to quality and affordable medicines.
29 September 2026 · The Standard →
Kenya is targeting local production of at least half its essential health products by 2030 under a new 2026–2030 Health Products and Technologies Local Manufacturing Strategy, aimed at reducing reliance on imports and strengthening pharmaceutical security. The government has said 13 new pharmaceutical companies have commenced operations in Kenya, with some already producing medicines and other health products for export.
28 September 2026 · Capital News →
The Pharmacy and Poisons Board has issued a public alert over falsified batches of Lucentis (Ranibizumab) 0.3mg injection circulating in Kenya, detected through post-marketing surveillance, with one person arrested in possession of the product. The fake product carries batch numbers 18862110 and 18802112 and falsely claims manufacture by Genentech, differing from the genuine Novartis product in labelling, dosage specification, and vial colour.
28 September 2026 · Citizen Digital →
A five-year project in Kenya is testing whether selected community pharmacies can provide contraceptive counselling, method choice and reproductive health services alongside dispensing, aiming to bridge the gap between simple commodity sales and quality family planning care. The Strengthening Pharmacy Provision of Contraceptives in Kenya Market Test project, implemented by inSupply Health with the Ministry of Health and partner organisations, began in 2021 to assess whether the expanded model works for both clients and businesses.
28 September 2026 · The Standard →
An opinion piece argues that pharmacy practice in Kenya has evolved beyond medicine dispensing to include patient counseling, disease management, and preventive care, requiring structures like Good Pharmacy Practice standards to ensure pharmacists meet the highest care standards.
25 September 2026 · The Standard →
The Anti-Counterfeit Authority reports that Kenya loses more than Sh153 billion annually to counterfeit trade in health, agriculture, electronics, and automotive sectors. The article notes that illicit trade is becoming normalised in everyday economic life, as consumers knowingly or unknowingly purchase counterfeit goods.
22 September 2026 · The Standard →
Taxpayers face losses of approximately Sh1 billion in expired medicines, prompting the Senate Health Committee to demand answers from the Pharmacy and Poisons Board over management, inspection and disposal gaps. A KEMSA report revealed that expired stock included drugs for cancer, HIV and malaria treatment, raising questions about weak inspection capacity, poor stock management and distribution delays.
18 September 2026 · Capital News →
The Pharmacy and Poisons Board has unveiled Good Pharmacy Practice (GPP) Standards at the Kenya Health Summit, setting expectations for pharmaceutical care. The piece argues that while individual provisions may require refinement, the standards represent progress toward fulfilling Kenyans' constitutional right to the highest attainable standard of health.
17 September 2026 · The Standard →
The Kenya Pharmaceutical Association and Kenya National Union of Pharmaceutical Technologists have threatened strike action over new Pharmacy and Poisons Board guidelines that restrict pharmacists without degree-level qualifications from practising in Level 3 and 4 health facilities. The associations say the rules are discriminatory and could damage healthcare operations as pharmacists constitute over 70 per cent of all healthcare practitioners.
7 September 2026 · The Standard →
The Pharmacy and Poisons Board has called for stronger quality assurance, safety monitoring and scientific research to ensure traditional medicines used in Kenya are safe, effective and of consistent quality, emphasizing accurate dosing, standardised production and clear product labelling.
6 September 2026 · The Standard →
The Ministry of Health has defended the 2026 Good Pharmacy Practice Standards following demonstrations by diploma-holding pharmacy professionals. Health Cabinet Secretary Aden Duale stated that the standards distinguish between pharmacy professionals and facility superintendents, and do not bar diploma or degree holders from practising provided they are duly registered, enrolled, and licensed within their respective legal scope.
4 September 2026 · Citizen Digital →
Kenya's medical research and disease surveillance is expected to improve through increased access to dry ice and specialised cold-chain services, which are critical for keeping biological samples at required temperatures during collection and transportation to laboratories. KEMRI notes that gaps in cold-chain facilities outside Nairobi can compromise sample integrity, particularly during disease outbreaks and for regional diagnostics work.
31 August 2026 · The Standard →
The Pharmacy and Poisons Board is strengthening oversight of storage, transportation and distribution of medicines through nationwide inspections of hospitals, retail pharmacies, wholesalers and transporters. During 2025/2026, PPB conducted 3,453 compliance inspections with an 82.4 per cent compliance rate, and the board says sustained oversight beyond manufacturing is necessary to ensure patients receive safe, quality products.
31 August 2026 · The Standard →
Kenya has attracted 13 new pharmaceutical manufacturers at various stages of establishment and operationalisation, strengthening the country's efforts to expand local production of medicines and health products. The Pharmacy and Poisons Board is providing regulatory guidance and technical support to ensure locally manufactured products meet quality, safety and efficacy standards.
27 August 2026 · The Standard →
An opinion piece warns that foreign researchers are extracting health data from low-income Kenyan communities to train AI medical devices that generate significant profits, with little or no benefit returning to the data sources. The author argues Kenya must secure ownership of its health data before such exploitation becomes entrenched.
26 August 2026 · The Standard →
The Pharmacy and Poisons Board says it has strengthened regulation of pharmacy practice and health products as part of reforms to protect patients and support Universal Health Coverage, including licensing of 15,679 pharmaceutical professionals and 11,141 premises, introducing Kenya's first Good Pharmacy Practice Standards, and digitising regulatory services.
21 August 2026 · Citizen Digital →
Deputy President Kindiki says the government is stepping up efforts to register all Kenyans under the Social Health Authority's Taifa Care programme, targeting 40 million enrollments by year-end after registering 32 million over the last two years, with a goal of universal registration by August next year.
19 August 2026 · Citizen Digital →
Deputy President Kindiki says the government aims to register 40 million Kenyans under the Social Health Authority (SHA) by the end of 2024, up from 32 million over the past two years, with a goal of universal coverage by August 2027.
19 August 2026 · Capital News →
A video circulating on social media has prompted questions about the authenticity and regulatory compliance of personal-care products on retail shelves, including items labelled Clodigte and Senodcseoly, though there is currently no independent verification that the products are counterfeit or substandard.
19 August 2026 · Citizen Digital →
The Pharmacy and Poisons Board has issued alerts about counterfeit Postinor-2 emergency contraceptives circulating in Kenya's market, part of a broader problem of sub-standard, expired, and fake medicines in hospital and pharmacy stores. The opinion argues that regulatory enforcement, port health authorities, and customs control mechanisms have failed in oversight, allowing counterfeit drugs to reach local chemists.
17 August 2026 · The Standard →
Kenya is implementing a medicine tracking system to combat counterfeit drugs. The Pharmacy and Poisons Board is leading efforts to tighten control over pharmaceuticals in the market.
17 August 2026 · The Standard →
The Pharmacy and Poisons Board has approved seven semaglutide-based medicines in Kenya, expanding treatment options for type 2 diabetes. Although the products share the same active ingredient, they do not necessarily have the same approved uses, and the regulator has warned the public against using semaglutide medicines without medical supervision, particularly for weight loss.
15 August 2026 · Citizen Digital →
The Pharmacy and Poisons Board has alerted the public to falsified Postinor-2 emergency contraceptive pills circulating in Kenya, warning that the counterfeits may contain incorrect or no active ingredient, harmful contaminants, or undeclared substances, potentially failing to prevent unintended pregnancies. The affected batch is Postinor-2, Batch No. T34197R, falsely claimed to be manufactured by Gedeon Richter, and can be distinguished from genuine products by printing differences, carton-sealing methods, and altered logo fonts on the authentication panel.
15 August 2026 · The Standard →
The Pharmacy and Poisons Board has warned of a falsified batch of Postinor-2 (emergency contraceptive) pills circulating in Kenya, identified as Batch Number T34197R. The counterfeit product differs from genuine pills in batch printing method, carton sealing, and patient information leaflet quality.
14 August 2026 · Citizen Digital →
The Pharmacy and Poisons Board has alerted the public to a fake batch of Postinor-2 (Levonorgestrel 0.75mg), batch number T34197R, falsely claiming manufacture by Gedeon Richter Plc. The counterfeit product differs from genuine stock in packaging, sealing, and printing methods, and may contain incorrect or no active ingredient, harmful contaminants, or undeclared substances.
14 August 2026 · The Standard →
The article argues that medicines regulation is essential to public health, ensuring patients receive safe, effective, and quality products through evaluation, manufacturing standards, secure supply chains, and post-market monitoring, particularly as Kenya advances Universal Health Coverage.
16 July 2026 · Citizen Digital →
An opinion piece argues that safe, effective medical products depend on rigorous regulatory processes—evaluation before market entry, manufacturing standards, secure supply chains, and post-market monitoring—which are essential as Kenya advances Universal Health Coverage.
16 July 2026 · Citizen Digital →
Health Cabinet Secretary Aden Duale announced plans to ban the delivery of antibiotics through boda boda riders as part of efforts to combat counterfeit medicines and illegal online sales of prescription drugs, stating that prescription drugs should only be dispensed through licensed pharmacies.
3 July 2026 · Citizen Digital →